Skip to main content

Table 4 Impact of Significant Treatment Variables on Treatment Satisfaction

From: Examining correlates of treatment satisfaction for injectable insulin in type 2 diabetes: lessons learned from a clinical trial comparing biphasic and basal analogues

  ITSQ Overall (n = 197) ITSQ IR (n = 196) ITSQ LF (n = 196) ITSQ HC (n = 197) ITSQ GC (n = 197) ITSQ DD (n = 197)
  Coefficient (t-ratio)
Intercept 108.93*** (13.06) 110.62*** (11.53) 62.46*** (7.52) 84.27*** (43.10) 124.26*** (12.73) 108.68*** (12.34)
Age    0.32* (2.04)    
Neuropathy (N = 0, Y = 1) -11.91** (-2.79) -7.97* (-2.38) -11.65* (-2.14) -12.36* (-2.26) -13.42** (-2.69) -8.63** (-2.79)
Retinopathy (N = 0, Y = 1)       9.36 (1.86)
Change in weight (BMI)    7.40 (1.69)    
Co-morbid conditions (number of diabetic related) 1.43 (0.55)   -0.22 (-0.01) 1.83 (0.56) 0.04 (0.01)  
HbA1c Level (week 28) -3.29** (-2.88) -3.19* (-2.43)    -5.17*** (-3.87) -3.19** (-2.65)
Number of hypoglycemic events during day (active 7 am-11 pm) -0.53** (-2.72) -0.29 (-1.28) -0.70** (-2.86) -0.81** (-3.26) -0.34 (-1.47) -0.42* (-2.06)
Number of hypoglycemic events during night (sleep 11 pm-7 am) 0.29 (0.72) 0.53 (1.14) 0.71 (1.41) -0.27 (-0.53) 0.15 (0.32) 0.36 (0.84)
  F = 65.351*** F = 3.177* F = 4.571*** F = 5.657*** F = 6.093*** F = 4.027**
  R2 = 0.123 R2 = 0.062 R2 = 0.125 R2 = 0.103 R2 = 0.138 R2 = 0.095
  Adj R2 = 0.100 Adj R2 = 0.043 Adj R2 = 0.098 Adj R2 = 0.085 Adj R2 = 0.115 Adj R2 = 0.072
  1. • * p < 0.05, ** p < 0.01, *** p < 0.001
  2. • IR = Inconvenience of Regime subscale, LF = Lifestyle Flexibility subscale, HC = Hypoglycemic Control subscale, GC = Glycemic Control subscale, DD = Device Delivery subscale